Elizabeth M. Kang

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Jonathan D. Powell, Griffin P. Rodgers, J. Powell, 2009, The New England journal of medicine.

Gene therapy-based treatment for HIV-positive patients with malignancies.

R. Morgan, A. Barrett, J. Tisdale, 2002, Journal of hematotherapy & stem cell research.

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

J. Tisdale, H. Malech, R. Wesley, 2008, Blood.

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.

R. Morgan, A. Barrett, J. Tisdale, 2002, Blood.

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

A. Barrett, M. Bishop, J. Tisdale, 2008, Blood.

Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.

A. Barrett, T. Fry, J. Tisdale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting.

N. Giri, J. Tisdale, Y. Hanazono, 2001, Human gene therapy.